DE SCR52

Designates May 2019 as "ALS Awareness Month" in the State of Delaware

Acknowledges that approximately 100 people are living with ALS in Delaware at any given time

Notes that military veterans are twice as likely as the general population to be diagnosed with ALS, classifying it as a service-connected disease

Recognizes that ALS is a progressive neurodegenerative disease with no cure and only 2 available treatment drugs, with patients typically living 2 to 5 years after diagnosis

Commends the ALS Association for supporting patients and families in Delaware and leading research, care services, and public policy efforts